The Boehringer Ingelheim Group is among the 20 largest pharmaceutical companies in the world. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 175 subsidiaries and a total of approximately 51,000 employees. The focus of the family-owned company founded in 1885 is the research, development, manufacture and commercialization of new drugs of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of Boehringer Ingelheim's corporate culture. This includes participation worldwide in social projects, such as the initiative "Making More Health” that has supported 100 fellows, whose health projects have impacted more than 9 million people in the world. Respect, equal opportunities and the reconciliation of work and family life constitute the basis of mutual cooperation. In everything it does, the company focuses on protecting the environment and sustainability.
In 2019, Boehringer Ingelheim achieved net sales of approximately € 19 billion. Investment in Research and Development corresponds to 18.2% of its net sales.